Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Versant Ventures V, LLC
2. Issuer Name and Ticker or Trading Symbol
Repare Therapeutics Inc. [ RPTX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
ONE SANSOME STREET, SUITE 3630
3. Date of Earliest Transaction (MM/DD/YY)
06/23/2020
(Street)
SAN FRANCISCO, CA94104
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 06/23/2020 C( 1 ) 2,054,198 A 2,705,660 I See Footnote ( 2 )
Common Shares 06/23/2020 C( 1 ) 156,335 A 205,915 I See Footnote ( 3 )
Common Shares 06/23/2020 C( 1 ) 68,398 A 90,090 I See Footnote ( 4 )
Common Shares 06/23/2020 C( 1 ) 61,791 A 81,387 I See Footnote ( 5 )
Common Shares 06/23/2020 C( 1 ) 2,443,883 A 2,443,883 I See Footnote ( 6 )
Common Shares 06/23/2020 C( 1 ) 111,361 A 2,817,021 I See Footnote ( 2 )
Common Shares 06/23/2020 C( 1 ) 8,475 A 214,390 I See Footnote ( 3 )
Common Shares 06/23/2020 C( 1 ) 3,708 A 93,798 I See Footnote ( 4 )
Common Shares 06/23/2020 C( 1 ) 3,350 A 84,737 I See Footnote ( 5 )
Common Shares 06/23/2020 C( 1 ) 875,568 A 3,319,451 I See Footnote ( 6 )
Common Shares 06/23/2020 C( 1 ) 458,282 A 458,282 I See Footnote ( 7 )
Common Shares 06/23/2020 P 150,000 A $ 20 608,282 I See Footnotes ( 7 ) ( 8 )
Common Shares 06/23/2020 P 100,000 A $ 20 3,419,451 I See Footnotes ( 6 ) ( 9 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class A Preferred Shares ( 1 ) 06/23/2020 C 2,054,198 ( 1 ) ( 1 ) Common Shares 2,054,198 ( 1 ) 0 I See Footnote ( 2 )
Class A Preferred Shares ( 1 ) 06/23/2020 C 156,335 ( 1 ) ( 1 ) Common Shares 156,335 ( 1 ) 0 I See Footnote ( 3 )
Class A Preferred Shares ( 1 ) 06/23/2020 C 68,398 ( 1 ) ( 1 ) Common Shares 68,398 ( 1 ) 0 I See Footnote ( 4 )
Class A Preferred Shares ( 1 ) 06/23/2020 C 61,791 ( 1 ) ( 1 ) Common Shares 61,791 ( 1 ) 0 I See Footnote ( 5 )
Class A Preferred Shares ( 1 ) 06/23/2020 C 2,443,883 ( 1 ) ( 1 ) Common Shares 2,443,883 ( 1 ) 0 I See Footnote ( 6 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 111,361 ( 1 ) ( 1 ) Common Shares 111,361 ( 1 ) 0 I See Footnote ( 2 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 8,475 ( 1 ) ( 1 ) Common Shares 8,475 ( 1 ) 0 I See Footnote ( 3 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 3,708 ( 1 ) ( 1 ) Common Shares 3,708 ( 1 ) 0 I See Footnote ( 4 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 3,350 ( 1 ) ( 1 ) Common Shares 3,350 ( 1 ) 0 I See Footnote ( 5 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 875,568 ( 1 ) ( 1 ) Common Shares 875,568 ( 1 ) 0 I See Footnote ( 6 )
Class B Preferred Shares ( 1 ) 06/23/2020 C 458,282 ( 1 ) ( 1 ) Common Shares 458,282 ( 1 ) 0 I See Footnote ( 7 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Versant Ventures V, LLC
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Ophthalmic Affiliates I, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Affiliates Fund V, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Venture Capital V (Canada), LP
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Ventures V GP-GP (Canada), Inc.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Venture Capital V, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Venture Capital VI, L.P.
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Ventures VI GP, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Ventures VI GP-GP, LLC
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA94104
X
Versant Ventures V (Canada), L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA
X
Signatures
/s/ Robin L. Praeger, Managing Director of Versant Ventures V, LLC 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Ventures V, LLC, general partner of Versant Ophthalmic Affiliates Fund I, L.P. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Ventures V, LLC, general partner of Versant Affiliates Fund V, L.P. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Director of Versant Ventures V GP-GP (Canada), Inc., general partner of Versant Ventures V (Canada) L.P., the general partner of Versant Venture Capital V (Canada) LP 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Director of Versant Ventures V GP-GP (Canada), Inc., general partner of Versant Ventures V (Canada) L.P. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Director of Versant Ventures V GP-GP (Canada), Inc. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Ventures VI GP-GP LLC, general partner of Versant Ventures VI GP, L.P., the general partner of Versant Venture Capital VI, L.P. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Ventures VI GP-GP LLC, general partner of Versant Ventures VI GP, L.P. 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Ventures VI GP-GP LLC 06/25/2020
** Signature of Reporting Person Date
/s/ Robin L. Praeger, Managing Director of Versant Venture Capital V, L.P. 06/25/2020
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )Each Class A Preferred share and each Class B Preferred Share converted into the same number of Common Shares upon the closing of the Issuer's initial public offering and had no expiration date.
( 2 )The securities are held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VVC V, except to the extent of its pecuniary interest therein.
( 3 )The securities are held by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). By virtue of such relationships, VV V (Canada) GP and VV V (Canada) may be deemed to have voting and investment power over the securities held by VVC V (Canada) and as a result may be deemed to have beneficial ownership over such securities. Each of VV V (Canada) and VV V (Canada) GP disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of its pecuniary interest therein.
( 4 )The securities are held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I and may be deemed to have voting and investment power over the securities held by VOAF I and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VOAF I, except to the extent of its pecuniary interest therein.
( 5 )The securities are held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities. VV V disclaims beneficial ownership of the shares held by VAF V, except to the extent of its pecuniary interest therein.
( 6 )The securities are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. By virtue of such relationships, VV VI GP and VV VI may be deemed to have voting and investment power over the securities held by VVC VI and as a result may be deemed to have beneficial ownership over such securities. Each of VV VI GP and VV VI disclaims beneficial ownership of the shares held by VVC VI, except to the extent of its pecuniary interest therein.
( 7 )The securities are held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. By virtue of such relationships, VV I GP and VV I GP-GP may be deemed to have voting and investment power over the securities held by VV I and as a result may be deemed to have beneficial ownership over such securities. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of its pecuniary interest therein.
( 8 )These securities were purchased by VV I.
( 9 )These securities were purchased by VVC VI.

Remarks:
1 of 2: Since there are 13 joint filers with this transaction and EDGAR will not allow for entry of more than 10 joint filers, this Form 4 is being filed in conjunction with a Form 4 for Versant Vantage I, LP, Versant Vantage I GP, L.P. and Versant Vantage I GP-GP, LLC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.